EPCAM and peritoneum cancer: For further study, Ang et al. reported that anti‐EpCAM CAR‐T cells exhibited specific in vitro killing activity against EpCAM‐positive human ovarian and colorectal cancer cells, and successfully treated local peritoneal cancer in xenograft mice with anti‐EpCAM CAR‐T cells, which show the feasibility of this therapy for curing clinical gastrointestinal and gynaecological malignancies.52